Buy Stocks Easy | About Us
January 24, 2022
Buy Stocks Easy | Online Stocks

IOVA


Buy Iovance Biotherapeutics, Inc. Stock (symbol: IOVA) Easy Online

Company Name: Iovance Biotherapeutics, Inc.

Symbol: IOVA

Sector: Health Care

Industry: Biotechnology: Biological Products (No Diagnostic Substances)

IPO: 2010

IOVA Current Share Price

Today's IOVA ( Iovance Biotherapeutics, Inc. ) opening price: $28.0000

Yesterday's IOVA ( Iovance Biotherapeutics, Inc. ) closing price: $28.0100

Iovance Biotherapeutics, Inc. Stock ( symbol: IOVA ) Price Chart since IPO (2010):

12 Months Iovance Biotherapeutics, Inc. Stock ( symbol: IOVA ) Price Chart

Popular Questions about Iovance Biotherapeutics, Inc. Public Stock ( IOVA )

A: Iovance Biotherapeutics, Inc. stock symbol (also called stock or share ticker) is IOVA

A: Iovance Biotherapeutics, Inc. IPO (Initial Public Offering) took place on 2010

A: Iovance Biotherapeutics, Inc.'s stock (IOVA symbol) price at ther IPO (initial Public Offering) was $28.0000

Q: Is IOVA stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Iovance Biotherapeutics, Inc. stock (symbol: IOVA) at the beginning of 2019, at the opening share price of $9.1500, with a minimum of $200, by now your shares would be worth $4570 and your profit would be $4370 - SHOW ONLY IF PROFIT.

Buy Iovance Biotherapeutics, Inc. Stock Easy Online

Iovance Biotherapeutics, Inc. Stock Ticker Price Chart since IPO:





Iovance Biotherapeutics, Inc. Stock Price Yesterday



 


Iovance Biotherapeutics, Inc. Stock Price – Last Week




 


Iovance Biotherapeutics, Inc. Stock Price – Last Month




 


Iovance Biotherapeutics, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            https://www.fool.com/investing/2019/12/09/2-top-biotech-stocks-to-buy-in-december.aspx
                            

                                
2 Top Biotech Stocks to Buy in December

                                
                                
These companies are carving their own paths in cellular medicines. ...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4309771-iovance-biotherapeutics-solving-solid-tumors-conundrum
                            

                                
Iovance Biotherapeutics: Solving The Solid Tumors Conundrum

                                
                                
Iovance Biotherapeutics: Solving The Solid Tumors Conundrum


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/21/1950663/0/en/Iovance-Biotherapeutics-Announces-Results-of-a-Subgroup-Analysis-of-Patients-in-the-Lifileucel-Metastatic-Melanoma-Study-who-are-Primary-Refractory-to-Anti-PD-1-L1-Therapy.html
                            

                                
Iovance Biotherapeutics Announces Results of a Subgroup Analysis of Patients in the Lifileucel Metastatic Melanoma Study who are Primary Refractory to Anti-PD-1/L1 Therapy

                                
                                
-  41 percent objective response rate (ORR) as assessed by the inve...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/11/09/3-cancer-treatment-stocks-to-buy-right-now.aspx
                            

                                
3 Cancer Treatment Stocks to Buy Right Now

                                
                                
MIrati Therapeutics, Iovance Biotherapeutics, and Personalis are al...


                            

                        
                    

                


                            

                    


                        
                            https://247wallst.com/healthcare-business/2019/11/08/melanoma-treatment-takes-a-big-step-forward/
                            

                                
Melanoma Treatment Takes a Big Step Forward

                                
                                
Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares jumped on Friday...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/02/1923948/0/en/Iovance-Biotherapeutics-Announces-Four-Abstracts-to-be-Presented-at-the-Upcoming-2019-SITC-Annual-Meeting.html
                            

                                
Iovance Biotherapeutics Announces Four Abstracts to be Presented at the Upcoming 2019 SITC Annual Meeting

                                
                                
SAN CARLOS, Calif., Oct.  02, 2019  (GLOBE NEWSWIRE) -- Iovance Bio...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2020/01/11/these-3-biotech-stocks-could-be-top-stocks-in-2020.aspx
                            

                                
These 3 Biotech Stocks Could Be Top Stocks in 2020

                                
                                
Fast-approaching catalysts could make these biotech stocks top perf...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/12/09/2-top-biotech-stocks-to-buy-in-december.aspx
                            

                                
2 Top Biotech Stocks to Buy in December

                                
                                
These companies are carving their own paths in cellular medicines. ...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4309771-iovance-biotherapeutics-solving-solid-tumors-conundrum
                            

                                
Iovance Biotherapeutics: Solving The Solid Tumors Conundrum

                                
                                
Iovance Biotherapeutics: Solving The Solid Tumors Conundrum


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/21/1950663/0/en/Iovance-Biotherapeutics-Announces-Results-of-a-Subgroup-Analysis-of-Patients-in-the-Lifileucel-Metastatic-Melanoma-Study-who-are-Primary-Refractory-to-Anti-PD-1-L1-Therapy.html
                            

                                
Iovance Biotherapeutics Announces Results of a Subgroup Analysis of Patients in the Lifileucel Metastatic Melanoma Study who are Primary Refractory to Anti-PD-1/L1 Therapy

                                
                                
-  41 percent objective response rate (ORR) as assessed by the inve...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/11/09/3-cancer-treatment-stocks-to-buy-right-now.aspx
                            

                                
3 Cancer Treatment Stocks to Buy Right Now

                                
                                
MIrati Therapeutics, Iovance Biotherapeutics, and Personalis are al...


                            

                        
                    

                


                            

                    


                        
                            https://247wallst.com/healthcare-business/2019/11/08/melanoma-treatment-takes-a-big-step-forward/
                            

                                
Melanoma Treatment Takes a Big Step Forward

                                
                                
Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares jumped on Friday...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.